Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitric Oxide for Endothelial Dysfunction in Cardiac Surgery
NCT03748082Phase 2Withdrawn
- Sponsor
- Massachusetts General Hospital
- Start
- Dec 2018
- Primary completion
- Nov 2023
- Modality
- DNA Intercalators/Alkylators, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 2 trial of nitric oxide in endothelial dysfunction, Intravascular hemolysis, sponsored by Massachusetts General Hospital. Planned start Dec 2018; status: withdrawn.
02
Drugs
nitric oxide
03
Conditions
endothelial dysfunctionIntravascular hemolysis
Beyond the preview
Go deeper on NCT03748082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03748082.